2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

OEIS National Registry Launched to Track Data on Vascular Interventions

April 28, 2017 -- The Outpatient Endovascular and Interventional Society (OEIS) announced the launch of the OEIS National Registry to collect and report data for all office-ba…

Data Presented for Biotronik's BIOFLEX PEACE and BIOLUX 4EVER Studies

April 27, 2017 -- Biotronik announced that data from the BIOFLEX PEACE all-comers registry and the BIOLUX 4EVER study were presented at the 2017 Charing Cross Symposium in Lon…

Contego's Vanguard IEP Balloon Angioplasty System Receives CE Mark Approval

April 27, 2017 -- Contego Medical LLC announced that it has received European CE Mark approval for its peripheral balloon angioplasty system with integrated embolic …

Five-Year Data From the ENGAGE Postmarket Registry Presented for Medtronic's Endurant II EVAR System

April 26, 2017 -- Medtronic announced that 5-year data from the ENGAGE global registry were presented by Philippe Cuypers, MD, at the 2017 Charing Cross Symposium in London, U…

Enrollment Begins in Mercator MedSystems' TANGO Trial

April 26, 2017 -- Mercator MedSystems, Inc. announced the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes…

FDA Approves Feasibility Study of LimFlow's PDVA System to Treat End-Stage CLI Patients

April 26, 2017 -- LimFlow SA announced that the US Food and Drug Administration has approved the company's investigational device exemption for a feasibilit…

Click here for more News coverage

Current Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Shaped and Sized for Embolization Success

Expert Case Experiences

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $43.64  -0.02%
AstraZeneca PLC $30.25  -1.98%
Avinger $0.56  -1.76%
Boston Scientific Corporation $26.38  0.76%
Cardinal Health $72.59  -0.75%
Cardiovascular Systems Inc. $29.87  0.00%
CR Bard Inc. $307.48  0.62%
Edwards Lifesciences Corp. $109.67  0.00%
Endologix Inc. $7.49  0.27%
Vascular Market Price  Change
Johnson and Johnson $123.47  -0.22%
Lombard Medical, Inc. $0.50  -0.40%
Medtronic, Inc. $83.09  -0.05%
Merit Medical Systems, Inc. $33.70  8.01%
Penumbra, Inc. $85.45  -0.70%
Stryker $136.37  0.74%
Teleflex Inc. $206.89  0.21%
The Medicines Company $49.32  1.52%
The Spectranetics Corporation $28.60  -2.05%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.